Compositions containing the nonprescription combination of aceta

Details Compositions containing the nonprescription combination of aceta Compositions containing the nonprescription combination of aceta

1998-02-10

1999-10-26

Spivack, Phyllis G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ortho-hydroxybenzoic acid or derivative doai

514264, 514630, A61K 3160, A61K 3152, A61K 31165

Patent

active

059729163

ABSTRACT:
The invention provides a safe and economical nonprescription combination of acetaminophen, aspirin and caffeine (APAP/ASA/CAF) for use in treating migraine pain and the cluster of symptoms characteristic of migraine attack, such as nausea, photophobia, phonophobia and functional disabilities. The use of the APAP/ASA/CAF combination is also effective in aborting the prodrome phase of a migraine attack.

REFERENCES:
patent: 3080287 (1963-03-01), Lewenstein
patent: 4017614 (1977-04-01), Wild
patent: 4585866 (1986-04-01), Fozard et al.
patent: 4758433 (1988-07-01), Johnson et al.
patent: 5273759 (1993-12-01), Simmons
patent: 5538959 (1996-07-01), Mauskop
Bosse et al., Treatment of headaches of very different origin, Therapiewoche 38, 3879-3884 (1998).
Physicians' Desk Reference for nonprescription drugs, 1990, p. 530.
Rasmussen, Birthe Krogh, et al., Impact of headache on sickness, absence and utilization of medical services: a Danish population study, Journal fo Epidemiology and Community Health, 1992; 46:443-446.
Lipton, Richard B., M.D., Gallup Poll of Migraine Sufferers, Headache Newslatter, Nov. 1995, american Council for Headache Education, Woodbury, N.J. 08096.
Edmeads, John et al., Impact of Migraine and Tension-Type Headache on Life Style, Consulting Behavior, and Medication Use: A Canadian Population Survey, the Canadian Journal of Neurological Sciences, May 1993, vol. 20, No. 2, p. 131-7.
Editorial, Over-the-Counter Medication and the Treatment of Migraine, Headache 1994; 34:547-548.
Stang, Paul E., Ph.D., PA-C, et al,; Migraine: Patterns of healthcare use, Neurology, Jun. 1994, 44(Suppl4): S47-S55.
Olesen, J., A review of current drugs for migraine, J. Neurol (1991) 238:S23-S27.
Laska, Eugene M., Ph.D, et al., Caffeine as an Analgesic Adjuvant, JAMA, Apr. 6, 1984; vol. 251, No. 13, p. 1711-18.
Migliardi, Joseph R., MD., et al., Caffeien as an analgesic adjuvant in tension headache, Clinical Pharmacology & Therapeutics, vol. 56, No. 5, p. 576-86.
Rasmussen, Birthe Krogh, et al., Migraine, Epidemiology, Headaches, Chapter 22, p. 169-173, Raven Press, New York, N.Y., 1993.
Solomon, Glen D., M.D. FACP, Therapeutic Advances in Migraine, J. Clin. Pharmacol 1993; 33: 200-209.
RoteListe 1995, p. 256.
Drug Launch, 94: 15622 (Aug. 1986).
Lehmann, Horst, et al., Studies on the Chronic Oral Toxicity of an Analgesic Drug Combination Consisting of Acetylsalicylic Acid, Paracetamol and Caffeine in Rats Including an Electron Microscopical Evaluation of Kidneys, Arzneim.-Forsch./Drug Res. 46(II), 895-905(1996).
G. Haag, Elzack-Oberprechtal; Deutsche Apotheker Zeitung, 1998: pp. 229-234.
Hans-Christoph Diener, Klaus-Ulrich Buhler, Johannes Dichgans, Stefan Geiselhart, Dieter Gerber, Erich Scholz, Tubingen; Arzneimitteltherapie, vol. 6, No. 5, 1988, pp. 156-164.

Affiliated with

Also associated with

Rating

Compositions containing the nonprescription combination of aceta does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions containing the nonprescription combination of aceta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions containing the nonprescription combination of aceta will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-764690